These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 7597668)
41. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Gustafsson PM; De Jong PA; Tiddens HA; Lindblad A Thorax; 2008 Feb; 63(2):129-34. PubMed ID: 17675316 [TBL] [Abstract][Full Text] [Related]
42. Cystic fibrosis and pregnancy. Jankelson D; Robinson M; Parsons S; Torzillo P; Peat B; Bye P Aust N Z J Obstet Gynaecol; 1998 May; 38(2):180-4. PubMed ID: 9653856 [TBL] [Abstract][Full Text] [Related]
43. [Cystic fibrosis in adults: inter- and intraobserver agreement for the Brasfield and Chrispin-Norman chest radiography scoring systems and correlation with clinical data and spirometry]. Gutiérrez V; Olivera MJ; Girón RM; Rodríguez-Salvanés F; Caballero P Arch Bronconeumol; 2005 Oct; 41(10):553-9. PubMed ID: 16266668 [TBL] [Abstract][Full Text] [Related]
45. The association between forced expiratory volume in one second (FEV1) and pulse oximetric measurements of arterial oxygen saturation (SpO2) in the patients with COPD: A preliminary study. Ardestani ME; Abbaszadeh M J Res Med Sci; 2014 Mar; 19(3):257-61. PubMed ID: 24949035 [TBL] [Abstract][Full Text] [Related]
46. Predicting arterial oxygen tension from maximum expiratory flow volume curves in cystic fibrosis. Stecenko AA; Postotnik L; Thomas RG Pediatr Pulmonol; 1989; 6(1):27-30. PubMed ID: 2704580 [TBL] [Abstract][Full Text] [Related]
47. [Evaluation of respiratory function tests in children and adolescents with type 1 diabetes]. Pieniawska A; Horodnicka-Józwa A; Petriczko E; Walczak M Pediatr Endocrinol Diabetes Metab; 2012; 18(1):15-20. PubMed ID: 22525686 [TBL] [Abstract][Full Text] [Related]
48. Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation. Hayes D; Kirkby S; Whitson BA; Black SM; Sheikh SI; Tobias JD; Mansour HM; Kopp BT Ann Thorac Surg; 2015 Aug; 100(2):474-9. PubMed ID: 26138770 [TBL] [Abstract][Full Text] [Related]
49. Long-term effects of aerosolised rhDNase on pulmonary disease progression in patients with cystic fibrosis. Milla CE Thorax; 1998 Dec; 53(12):1014-7. PubMed ID: 10195070 [TBL] [Abstract][Full Text] [Related]
50. Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States. McGarry ME; Neuhaus JM; Nielson DW; Ly NP Pediatr Pulmonol; 2019 Sep; 54(9):1382-1390. PubMed ID: 31144477 [TBL] [Abstract][Full Text] [Related]
51. Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial. Bakker EM; Volpi S; Salonini E; Müllinger B; Kroneberg P; Bakker M; Hop WC; Assael BM; Tiddens HA Pediatr Pulmonol; 2014 Feb; 49(2):154-61. PubMed ID: 23913868 [TBL] [Abstract][Full Text] [Related]
52. Evidence of diminished FEV1 and FVC in 6-year-olds followed in the European Cystic Fibrosis Patient Registry, 2007-2009. VanDevanter DR; Pasta DJ J Cyst Fibros; 2013 Dec; 12(6):786-9. PubMed ID: 23632449 [TBL] [Abstract][Full Text] [Related]
54. Sources of variation in FEV1. Coates AL; Desmond KJ; Demizio D; Allen PD Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 1):439-43. PubMed ID: 8306042 [TBL] [Abstract][Full Text] [Related]
55. Improved air trapping evaluation in chest computed tomography in children with cystic fibrosis using real-time spirometric monitoring and biofeedback. Kongstad T; Buchvald FF; Green K; Lindblad A; Robinson TE; Nielsen KG J Cyst Fibros; 2013 Dec; 12(6):559-66. PubMed ID: 23810566 [TBL] [Abstract][Full Text] [Related]
56. Predicting hypoxaemia during flights in children with cystic fibrosis. Buchdahl RM; Babiker A; Bush A; Cramer D Thorax; 2001 Nov; 56(11):877-9. PubMed ID: 11641514 [TBL] [Abstract][Full Text] [Related]
57. The mechanical effects of expiratory airflow limitation on cardiac performance in cystic fibrosis. Hortop J; Desmond KJ; Coates AL Am Rev Respir Dis; 1988 Jan; 137(1):132-7. PubMed ID: 3337453 [TBL] [Abstract][Full Text] [Related]
58. Pulmonary hypertension as estimated by Doppler echocardiography in adolescent and adult patients with cystic fibrosis and their relationship with clinical, lung function and sleep findings. Ziegler B; Perin C; Casarotto FC; Fagondes SC; Menna-Barreto SS; Dalcin PTR Clin Respir J; 2018 Feb; 12(2):754-761. PubMed ID: 27925430 [TBL] [Abstract][Full Text] [Related]
59. Exercise capacity reflects airflow limitation rather than hypoxaemia in patients with pulmonary arteriovenous malformations. Gawecki F; Strangeways T; Amin A; Perks J; McKernan H; Thurainatnam S; Rizvi A; Jackson JE; Santhirapala V; Myers J; Brown J; Howard LSGE; Tighe HC; Shovlin CL QJM; 2019 May; 112(5):335-342. PubMed ID: 30657990 [TBL] [Abstract][Full Text] [Related]
60. Nutritional growth retardation is associated with defective lung growth in cystic fibrosis: a preventable determinant of progressive pulmonary dysfunction. Thomson MA; Quirk P; Swanson CE; Thomas BJ; Holt TL; Francis PJ; Shepherd RW Nutrition; 1995; 11(4):350-4. PubMed ID: 8580575 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]